Cardiac Sarcoidosis Clinical Trials

38 clinical trials for Cardiac Sarcoidosis across international registries, including 14 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Cardiac Sarcoidosis Randomized Trial — RECRUITING · PHASE3
• Cardiac Sarcoidosis Multi-Center Prospective Cohort — RECRUITING
• [68Ga]Ga-PentixaFor PET/CT in Acute Myocardial Inflammation — RECRUITING · PHASE2
• Mayo AVC Registry and Biobank — RECRUITING
• Repurposing Tilmanocept for Cardiac Sarcoidosis — RECRUITING · PHASE2
• Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques — RECRUITING
• Diagnostic Utility of SGLT1/2 Inhibition to Facilitate Myocardial Glucose Suppression — RECRUITING
• Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition — RECRUITING
• Rilonacept in Subjects With Cardiac Sarcoidosis — RECRUITING · PHASE2
• Evaluation of the Prognostic Value of PET/MRI in Cardiac Sarcoidosis — RECRUITING · NA
• Macrophage PET/CT Imaging Using 64Cu-DOTATATE for the Diagnosis of Cardiac Sarcoidosis — RECRUITING
• Diagnostic Criteria in Cardiac Sarcoidosis — RECRUITING
• 18F-FLUORODEOXYGLUCOSE IN POSITRON EMISSION TOMOGRAPHY — RECRUITING
• CARDIAC SARCOIDOSIS MULTI-CENTER RANDOMIZED CONTROLLED TRIAL (CHASM CS- RCT) — RECRUITING
• Accuracy for Imaging Cardiac Sarcoidosis with 68Ga-Pentixafor Positron Emission Tomography/Computed Tomography (68Ga-Pentixafor PET/CT): ASPECT study — NOT_YET_RECRUITING · PHASE2
• Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis — TERMINATED · PHASE2
• Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS) — NOT_YET_RECRUITING
• Development and Validation of a Health-related Quality of Life Tool for Patients With Cardiac Sarcoidosis — COMPLETED
• A Trial of Baricitinib in Patients With Cardiac Sarcoidosis — NOT_YET_RECRUITING · PHASE2
• Interleukin-1 Blockade for Treatment of Cardiac Sarcoidosis — COMPLETED · PHASE2
• Evaluation of the Impact of a Patient Education Protocol on the Quality of 18F-FDG PET Imaging Indicated for Investigation of Cardiac Inflammation — NOT_YET_RECRUITING · NA
• UTSW HP [13-C] Pyruvate Injection in HCM — COMPLETED
• Routine Cardiac Screening in Sarcoidosis Patients — COMPLETED
• Inflammatory Cardiomyopathy Bern Registry — ACTIVE_NOT_RECRUITING
• Somatostatin Receptor Imaging in Acute Myocarditis and Cardiac Sarcoidosis — COMPLETED · NA
• Phase II study to assess in vivo imaging of MMR-expressing macrophages in cardiac sarcoidosis using 68Ga-NOTA-Anti-MMR-VHH2 Positron Emission Tomography (PET). — NOT_YET_RECRUITING · PHASE2
• PET/MR Imaging In Patients With Cardiac Sarcoidosis — COMPLETED · NA
• Feasibility and Accuracy of Hybrid Magnetic Resonance and Positron Emission Tomography With 18F-Fluorodeoxyglucose in Diagnosing Cardiac Sarcoidosis — TERMINATED · NA
• CASPA: CArdiac Sarcoidosis in PApworth — COMPLETED
• 18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation — TERMINATED · PHASE2
• Biomaterial Collection - and Analysis in Cardiac Sarcoidosis — NOT_YET_RECRUITING
• PET Imaging in Patients With Suspected Cardiac Sarcoidosis — COMPLETED
• 18F-FDG PET Imaging in Cardiac Sarcoidosis — OTHER
• d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis — COMPLETED · PHASE4
• Somatostatin Receptor Imaging in Cardiac Sarcoidosis — WITHDRAWN
• Non-Invasive Characterization in Cardiac Sarcoidosis — TERMINATED · NA
• Cardiac Sarcoidosis: FDG PET vs. Ga-DOTANOC PET — COMPLETED
• Cardiac Sarcoidosis Response To Steroids Trial — WITHDRAWN · PHASE4

Refine this search